Literature DB >> 8182133

Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein and scavenger receptor in human atherosclerotic lesions.

J Luoma1, T Hiltunen, T Särkioja, S K Moestrup, J Gliemann, T Kodama, T Nikkari, S Ylä-Herttuala.   

Abstract

Macrophage- and smooth muscle cell (SMC)-derived foam cells are typical constituents of human atherosclerotic lesions. At least three receptor systems have been characterized that could be involved in the development of foam cells: alpha 2-macroglobulin receptor/LDL receptor-related protein (alpha 2 MR/LRP), scavenger receptor, and LDL receptor. We studied the expression of these receptors in human atherosclerotic lesions with in situ hybridization and immunocytochemistry. An abundant expression of alpha 2MR/LRP mRNA and protein was found in SMC and macrophages in both early and advanced lesions in human aortas. alpha 2MR/LRP was also present in SMC in normal aortas. Scavenger receptor mRNA and protein were expressed in lesion macrophages but no expression was found in lesion SMC. LDL receptor was absent from the lesion area but was expressed in some aortas in medial SMC located near the adventitial border. The results demonstrate that (a) alpha 2MR/LRP is, so far, the only lipoprotein receptor expressed in lesions SMC in vivo; (b) scavenger receptors are expressed only in lesion macrophages; and (c) both receptors may play important roles in the development of human atherosclerotic lesions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8182133      PMCID: PMC294312          DOI: 10.1172/JCI117195

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  55 in total

1.  Localization of apolipoprotein E in normal and atherosclerotic human aorta.

Authors:  V R Babaev; A D Dergunov; A A Chenchik; E M Tararak; E V Yanushevskaya; I N Trakht; C Sorg; V N Smirnov
Journal:  Atherosclerosis       Date:  1990-12       Impact factor: 5.162

2.  Gene expression in macrophage-rich human atherosclerotic lesions. 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts.

Authors:  S Ylä-Herttuala; M E Rosenfeld; S Parthasarathy; E Sigal; T Särkioja; J L Witztum; D Steinberg
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

3.  39-kDa protein modulates binding of ligands to low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor.

Authors:  J Herz; J L Goldstein; D K Strickland; Y K Ho; M S Brown
Journal:  J Biol Chem       Date:  1991-11-05       Impact factor: 5.157

4.  Analysis of ligand recognition by the purified alpha 2-macroglobulin receptor (low density lipoprotein receptor-related protein). Evidence that high affinity of alpha 2-macroglobulin-proteinase complex is achieved by binding to adjacent receptors.

Authors:  S K Moestrup; J Gliemann
Journal:  J Biol Chem       Date:  1991-07-25       Impact factor: 5.157

5.  Alpha 2-macroglobulin-proteinase complexes, plasminogen activator inhibitor type-1-plasminogen activator complexes, and receptor-associated protein bind to a region of the alpha 2-macroglobulin receptor containing a cluster of eight complement-type repeats.

Authors:  S K Moestrup; T L Holtet; M Etzerodt; H C Thøgersen; A Nykjaer; P A Andreasen; H H Rasmussen; L Sottrup-Jensen; J Gliemann
Journal:  J Biol Chem       Date:  1993-06-25       Impact factor: 5.157

6.  Activated alpha 2-macroglobulin and transforming growth factor-beta 1 induce a synergistic smooth muscle cell proliferative response.

Authors:  G A Stouffer; J LaMarre; S L Gonias; G K Owens
Journal:  J Biol Chem       Date:  1993-08-25       Impact factor: 5.157

7.  The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds lipoprotein lipase and beta-migrating very low density lipoprotein associated with the lipase.

Authors:  A Nykjaer; G Bengtsson-Olivecrona; A Lookene; S K Moestrup; C M Petersen; W Weber; U Beisiegel; J Gliemann
Journal:  J Biol Chem       Date:  1993-07-15       Impact factor: 5.157

8.  Abundant expression of apoprotein E by macrophages in human and rabbit atherosclerotic lesions.

Authors:  M E Rosenfeld; S Butler; V A Ord; B A Lipton; C A Dyer; L K Curtiss; W Palinski; J L Witztum
Journal:  Arterioscler Thromb       Date:  1993-09

9.  Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein.

Authors:  U Beisiegel; W Weber; G Bengtsson-Olivecrona
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

10.  Lipoprotein lipase induces catabolism of normal triglyceride-rich lipoproteins via the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor in vitro. A process facilitated by cell-surface proteoglycans.

Authors:  D A Chappell; G L Fry; M A Waknitz; L E Muhonen; M W Pladet; P H Iverius; D K Strickland
Journal:  J Biol Chem       Date:  1993-07-05       Impact factor: 5.157

View more
  20 in total

1.  Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: relationship to tissue AGEs.

Authors:  A W Stitt; C He; S Friedman; L Scher; P Rossi; L Ong; H Founds; Y M Li; R Bucala; H Vlassara
Journal:  Mol Med       Date:  1997-09       Impact factor: 6.354

2.  Dual use of amphiphilic macromolecules as cholesterol efflux triggers and inhibitors of macrophage athero-inflammation.

Authors:  Nicole M Iverson; Nicole M Plourde; Sarah M Sparks; Jinzhong Wang; Ekta N Patel; Pratik S Shah; Daniel R Lewis; Kyle R Zablocki; Gary B Nackman; Kathryn E Uhrich; Prabhas V Moghe
Journal:  Biomaterials       Date:  2011-08-03       Impact factor: 12.479

3.  Involvement of specific macrophage-lineage cells surrounding arterioles in barrier and scavenger function in brain cortex.

Authors:  M Mato; S Ookawara; A Sakamoto; E Aikawa; T Ogawa; U Mitsuhashi; T Masuzawa; H Suzuki; M Honda; Y Yazaki; E Watanabe; J Luoma; S Yla-Herttuala; I Fraser; S Gordon; T Kodama
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

4.  Effect of dietary cholesterol on low density lipoprotein-receptor, 3-hydroxy-3-methylglutaryl-CoA reductase, and low density lipoprotein receptor-related protein mRNA expression in healthy humans.

Authors:  P Boucher; M de Lorgeril; P Salen; P Crozier; J Delaye; J J Vallon; A Geyssant; R Dante
Journal:  Lipids       Date:  1998-12       Impact factor: 1.880

5.  Heat-shock response is associated with decreased production of interleukin-6 in murine aortic vascular smooth muscle cells.

Authors:  InKyeom Kim; Heung-Mook Shin; Woonyi Baek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-01-18       Impact factor: 3.000

Review 6.  The response-to-retention hypothesis of early atherogenesis.

Authors:  K J Williams; I Tabas
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-05       Impact factor: 8.311

7.  The effect of fenofibrate treatment on endothelium-dependent relaxation induced by oxidative modified low density lipoprotein from hyperlipidemic patients.

Authors:  B Liang; J C McMaster; E A Kroeger; G M Hatch; D Mymin; T Dembinski; G Arthur; G Shen; R Y Man; P C Choy
Journal:  Mol Cell Biochem       Date:  2000-04       Impact factor: 3.396

8.  K Domain CR9 of Low Density Lipoprotein (LDL) Receptor-related Protein 1 (LRP1) Is Critical for Aggregated LDL-induced Foam Cell Formation from Human Vascular Smooth Muscle Cells.

Authors:  Paula Costales; Pablo Fuentes-Prior; Jose Castellano; Elena Revuelta-Lopez; Maria Ángeles Corral-Rodríguez; Laura Nasarre; Lina Badimon; Vicenta Llorente-Cortes
Journal:  J Biol Chem       Date:  2015-04-27       Impact factor: 5.157

9.  Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines.

Authors:  H Li; M W Freeman; P Libby
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

10.  Increased ferritin gene expression in atherosclerotic lesions.

Authors:  J H Pang; M J Jiang; Y L Chen; F W Wang; D L Wang; S H Chu; L Y Chau
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.